Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Vanta Bioscience Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vanta Bioscience Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vanta Bioscience - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    7 Jan 2025, 4:39PM Scrutinizers Report and Voting Results
  • Vanta Bioscience - Shareholder Meeting / Postal Ballot-Outcome of EGM

    4 Jan 2025, 9:04PM Proceedings of EGM held on 04.01.2025

Key fundamentals

Evaluate the intrinsic value of Vanta Bioscience Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 45.1729 45.5003 44.7576 37.2079 35.7512
Liabilities 45.1729 45.5003 44.7576 37.2079 35.7512
Equity 6.312 6.312 6.312 6.312 6.312
Gross Profit 3.6522 -0.4755 3.4018 3.8934 4.3163
Net Profit 0.051 -4.2354 0.0785 0.4702 0.978
Cash From Operating Activities 4.5421 0.6447 6.7025 10.9111 2.9525
NPM(%) 0.59 -81.9 0.83 4.68 6.92
Revenue 8.5579 5.1709 9.3498 10.0383 14.113
Expenses 4.9056 5.6465 5.948 6.1448 9.7966
ROE(%) 0.38 -32.25 0.59 3.58 7.44

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vanta Bioscience Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 17.55 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 63.95 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 132.78 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 60.30 -239.30 0.00

Company Info

The Company was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name "Vanta Bioscience Private Limited`. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to "Vanta Bioscience Limited" and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017. The corporate identification number is U74999TG2016PLC109280. The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company. Major Events and Milestones 2016 - Incorporation of the Company 2017 - The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as ?Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601201.

The Company was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name "Vanta Bioscience Private Limited`. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to "Vanta Bioscience Limited" and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017. The corporate identification number is U74999TG2016PLC109280. The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company. Major Events and Milestones 2016 - Incorporation of the Company 2017 - The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as ?Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601201.

Read More

Parent Organisation

Vanta Bioscience Ltd.

Founded

29/04/2016

Managing Director

Mr.Dopesh Raja Mulakala

NSE Symbol

FAQ

The current price of Vanta Bioscience Ltd is

The 52-week high for Vanta Bioscience Ltd is

The market capitalization of Vanta Bioscience Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vanta Bioscience Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vanta Bioscience Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vanta Bioscience Ltd shares.

The CEO of Vanta Bioscience Ltd is Mr.Dopesh Raja Mulakala, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT